Skip to main content

Carson Advisory Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1909304 ATHENS, GA

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$476,049
-$76,971 QoQ
Shares Held
3,768
-5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,395
of 2,266 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Carson Advisory Inc. holds $6,148,880 across 8 Drug Manufacturers - General names. GILD ranks #5 (7.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GILD
Gilead Sciences, Inc.
This page
3,768 $476,049

All Filings in GILD

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $476,049 3,768
2026-03-31 $553,020 3,968
2025-12-31 $487,032 3,968
2025-09-30 $436,008 3,928
2025-06-30 $457,671 4,128
2025-03-31 $518,567 4,628
2024-12-31 $427,488 4,628
2024-09-30 $413,163 4,928
2024-06-30 $338,110 4,928
2024-03-31 $360,976 4,928
2023-12-31 $399,217 4,928
2023-09-30 $367,131 4,899
2023-06-30 $377,565 4,899
2023-03-31 $439,658 5,299
2022-12-31 $515,014 5,999